0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lung Cancer Screening Software Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6V6111
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Lung Cancer Screening Software Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Lung Cancer Screening Software Market Research Report 2025

Code: QYRE-Auto-6V6111
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lung Cancer Screening Software Market

The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Lung Cancer Screening Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lung Cancer Screening Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lung Cancer Screening Software in Control and Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lung Cancer Screening Software include Nuance Communications Inc., Eon, Koninklijke Philips N.V., Siemens Healthineers AG, PenRad Technologies Inc., MRS Systems Inc., Magview, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Screening Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Screening Software.
The Lung Cancer Screening Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Screening Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer Screening Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lung Cancer Screening Software Market Report

Report Metric Details
Report Name Lung Cancer Screening Software Market
Segment by Type
  • Cloud-Based
  • Web-Based
Segment by Application
  • Control and Monitoring
  • Data Management
  • Decision Support
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nuance Communications Inc., Eon, Koninklijke Philips N.V., Siemens Healthineers AG, PenRad Technologies Inc., MRS Systems Inc., Magview
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lung Cancer Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lung Cancer Screening Software Market report?

Ans: The main players in the Lung Cancer Screening Software Market are Nuance Communications Inc., Eon, Koninklijke Philips N.V., Siemens Healthineers AG, PenRad Technologies Inc., MRS Systems Inc., Magview

What are the Application segmentation covered in the Lung Cancer Screening Software Market report?

Ans: The Applications covered in the Lung Cancer Screening Software Market report are Control and Monitoring, Data Management, Decision Support

What are the Type segmentation covered in the Lung Cancer Screening Software Market report?

Ans: The Types covered in the Lung Cancer Screening Software Market report are Cloud-Based, Web-Based

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Screening Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud-Based
1.2.3 Web-Based
1.3 Market by Application
1.3.1 Global Lung Cancer Screening Software Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Control and Monitoring
1.3.3 Data Management
1.3.4 Decision Support
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Screening Software Market Perspective (2020-2031)
2.2 Global Lung Cancer Screening Software Growth Trends by Region
2.2.1 Global Lung Cancer Screening Software Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lung Cancer Screening Software Historic Market Size by Region (2020-2025)
2.2.3 Lung Cancer Screening Software Forecasted Market Size by Region (2026-2031)
2.3 Lung Cancer Screening Software Market Dynamics
2.3.1 Lung Cancer Screening Software Industry Trends
2.3.2 Lung Cancer Screening Software Market Drivers
2.3.3 Lung Cancer Screening Software Market Challenges
2.3.4 Lung Cancer Screening Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Screening Software Players by Revenue
3.1.1 Global Top Lung Cancer Screening Software Players by Revenue (2020-2025)
3.1.2 Global Lung Cancer Screening Software Revenue Market Share by Players (2020-2025)
3.2 Global Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lung Cancer Screening Software Revenue
3.4 Global Lung Cancer Screening Software Market Concentration Ratio
3.4.1 Global Lung Cancer Screening Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Screening Software Revenue in 2024
3.5 Global Key Players of Lung Cancer Screening Software Head office and Area Served
3.6 Global Key Players of Lung Cancer Screening Software, Product and Application
3.7 Global Key Players of Lung Cancer Screening Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Screening Software Breakdown Data by Type
4.1 Global Lung Cancer Screening Software Historic Market Size by Type (2020-2025)
4.2 Global Lung Cancer Screening Software Forecasted Market Size by Type (2026-2031)
5 Lung Cancer Screening Software Breakdown Data by Application
5.1 Global Lung Cancer Screening Software Historic Market Size by Application (2020-2025)
5.2 Global Lung Cancer Screening Software Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lung Cancer Screening Software Market Size (2020-2031)
6.2 North America Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lung Cancer Screening Software Market Size by Country (2020-2025)
6.4 North America Lung Cancer Screening Software Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Screening Software Market Size (2020-2031)
7.2 Europe Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lung Cancer Screening Software Market Size by Country (2020-2025)
7.4 Europe Lung Cancer Screening Software Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Screening Software Market Size (2020-2031)
8.2 Asia-Pacific Lung Cancer Screening Software Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2020-2025)
8.4 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer Screening Software Market Size (2020-2031)
9.2 Latin America Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lung Cancer Screening Software Market Size by Country (2020-2025)
9.4 Latin America Lung Cancer Screening Software Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Screening Software Market Size (2020-2031)
10.2 Middle East & Africa Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2020-2025)
10.4 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nuance Communications Inc.
11.1.1 Nuance Communications Inc. Company Details
11.1.2 Nuance Communications Inc. Business Overview
11.1.3 Nuance Communications Inc. Lung Cancer Screening Software Introduction
11.1.4 Nuance Communications Inc. Revenue in Lung Cancer Screening Software Business (2020-2025)
11.1.5 Nuance Communications Inc. Recent Development
11.2 Eon
11.2.1 Eon Company Details
11.2.2 Eon Business Overview
11.2.3 Eon Lung Cancer Screening Software Introduction
11.2.4 Eon Revenue in Lung Cancer Screening Software Business (2020-2025)
11.2.5 Eon Recent Development
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Details
11.3.2 Koninklijke Philips N.V. Business Overview
11.3.3 Koninklijke Philips N.V. Lung Cancer Screening Software Introduction
11.3.4 Koninklijke Philips N.V. Revenue in Lung Cancer Screening Software Business (2020-2025)
11.3.5 Koninklijke Philips N.V. Recent Development
11.4 Siemens Healthineers AG
11.4.1 Siemens Healthineers AG Company Details
11.4.2 Siemens Healthineers AG Business Overview
11.4.3 Siemens Healthineers AG Lung Cancer Screening Software Introduction
11.4.4 Siemens Healthineers AG Revenue in Lung Cancer Screening Software Business (2020-2025)
11.4.5 Siemens Healthineers AG Recent Development
11.5 PenRad Technologies Inc.
11.5.1 PenRad Technologies Inc. Company Details
11.5.2 PenRad Technologies Inc. Business Overview
11.5.3 PenRad Technologies Inc. Lung Cancer Screening Software Introduction
11.5.4 PenRad Technologies Inc. Revenue in Lung Cancer Screening Software Business (2020-2025)
11.5.5 PenRad Technologies Inc. Recent Development
11.6 MRS Systems Inc.
11.6.1 MRS Systems Inc. Company Details
11.6.2 MRS Systems Inc. Business Overview
11.6.3 MRS Systems Inc. Lung Cancer Screening Software Introduction
11.6.4 MRS Systems Inc. Revenue in Lung Cancer Screening Software Business (2020-2025)
11.6.5 MRS Systems Inc. Recent Development
11.7 Magview
11.7.1 Magview Company Details
11.7.2 Magview Business Overview
11.7.3 Magview Lung Cancer Screening Software Introduction
11.7.4 Magview Revenue in Lung Cancer Screening Software Business (2020-2025)
11.7.5 Magview Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lung Cancer Screening Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cloud-Based
 Table 3. Key Players of Web-Based
 Table 4. Global Lung Cancer Screening Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Lung Cancer Screening Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Lung Cancer Screening Software Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Lung Cancer Screening Software Market Share by Region (2020-2025)
 Table 8. Global Lung Cancer Screening Software Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Lung Cancer Screening Software Market Share by Region (2026-2031)
 Table 10. Lung Cancer Screening Software Market Trends
 Table 11. Lung Cancer Screening Software Market Drivers
 Table 12. Lung Cancer Screening Software Market Challenges
 Table 13. Lung Cancer Screening Software Market Restraints
 Table 14. Global Lung Cancer Screening Software Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Lung Cancer Screening Software Market Share by Players (2020-2025)
 Table 16. Global Top Lung Cancer Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2024)
 Table 17. Ranking of Global Top Lung Cancer Screening Software Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Lung Cancer Screening Software Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Lung Cancer Screening Software, Headquarters and Area Served
 Table 20. Global Key Players of Lung Cancer Screening Software, Product and Application
 Table 21. Global Key Players of Lung Cancer Screening Software, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Lung Cancer Screening Software Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Lung Cancer Screening Software Revenue Market Share by Type (2020-2025)
 Table 25. Global Lung Cancer Screening Software Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Lung Cancer Screening Software Revenue Market Share by Type (2026-2031)
 Table 27. Global Lung Cancer Screening Software Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Lung Cancer Screening Software Revenue Market Share by Application (2020-2025)
 Table 29. Global Lung Cancer Screening Software Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Lung Cancer Screening Software Revenue Market Share by Application (2026-2031)
 Table 31. North America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Lung Cancer Screening Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Lung Cancer Screening Software Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Lung Cancer Screening Software Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Nuance Communications Inc. Company Details
 Table 47. Nuance Communications Inc. Business Overview
 Table 48. Nuance Communications Inc. Lung Cancer Screening Software Product
 Table 49. Nuance Communications Inc. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 50. Nuance Communications Inc. Recent Development
 Table 51. Eon Company Details
 Table 52. Eon Business Overview
 Table 53. Eon Lung Cancer Screening Software Product
 Table 54. Eon Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 55. Eon Recent Development
 Table 56. Koninklijke Philips N.V. Company Details
 Table 57. Koninklijke Philips N.V. Business Overview
 Table 58. Koninklijke Philips N.V. Lung Cancer Screening Software Product
 Table 59. Koninklijke Philips N.V. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 60. Koninklijke Philips N.V. Recent Development
 Table 61. Siemens Healthineers AG Company Details
 Table 62. Siemens Healthineers AG Business Overview
 Table 63. Siemens Healthineers AG Lung Cancer Screening Software Product
 Table 64. Siemens Healthineers AG Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 65. Siemens Healthineers AG Recent Development
 Table 66. PenRad Technologies Inc. Company Details
 Table 67. PenRad Technologies Inc. Business Overview
 Table 68. PenRad Technologies Inc. Lung Cancer Screening Software Product
 Table 69. PenRad Technologies Inc. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 70. PenRad Technologies Inc. Recent Development
 Table 71. MRS Systems Inc. Company Details
 Table 72. MRS Systems Inc. Business Overview
 Table 73. MRS Systems Inc. Lung Cancer Screening Software Product
 Table 74. MRS Systems Inc. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 75. MRS Systems Inc. Recent Development
 Table 76. Magview Company Details
 Table 77. Magview Business Overview
 Table 78. Magview Lung Cancer Screening Software Product
 Table 79. Magview Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)
 Table 80. Magview Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Lung Cancer Screening Software Picture
 Figure 2. Global Lung Cancer Screening Software Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lung Cancer Screening Software Market Share by Type: 2024 VS 2031
 Figure 4. Cloud-Based Features
 Figure 5. Web-Based Features
 Figure 6. Global Lung Cancer Screening Software Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lung Cancer Screening Software Market Share by Application: 2024 VS 2031
 Figure 8. Control and Monitoring Case Studies
 Figure 9. Data Management Case Studies
 Figure 10. Decision Support Case Studies
 Figure 11. Lung Cancer Screening Software Report Years Considered
 Figure 12. Global Lung Cancer Screening Software Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Lung Cancer Screening Software Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Lung Cancer Screening Software Market Share by Region: 2024 VS 2031
 Figure 15. Global Lung Cancer Screening Software Market Share by Players in 2024
 Figure 16. Global Top Lung Cancer Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Screening Software Revenue in 2024
 Figure 18. North America Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Lung Cancer Screening Software Market Share by Country (2020-2031)
 Figure 20. United States Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Lung Cancer Screening Software Market Share by Country (2020-2031)
 Figure 24. Germany Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Lung Cancer Screening Software Market Share by Region (2020-2031)
 Figure 32. China Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Lung Cancer Screening Software Market Share by Country (2020-2031)
 Figure 40. Mexico Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Lung Cancer Screening Software Market Share by Country (2020-2031)
 Figure 44. Turkey Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Nuance Communications Inc. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 48. Eon Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 49. Koninklijke Philips N.V. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 50. Siemens Healthineers AG Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 51. PenRad Technologies Inc. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 52. MRS Systems Inc. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 53. Magview Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India